3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement

3P Biopharmaceuticals and SpyBIotech agreement

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. Oxford, UK-based SpyBiotech selected 3P Biopharmaceuticals in June 2019 to manufacture a cGMP batch of […]

Validation batches of the vaccine against equine strangles Strangvac® is completed

vaccine against equine strangles Strangvac

3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics has, together with the Swedish biotechnology company Intervacc AB and LIOF-Pharma (previously Praxis Pharmaceutical), completed the manufacturing process for the vaccine against equine strangles called Strangvac®. The validation production batches required for the forthcoming registration application to the European Medicines […]